Company Search:
Advanced Search
Sponsored Links
Enzymatica AB (publ) Company Snapshot
Enzymatica AB (publ) operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Enzymatica AB (publ) with three other pharmaceutical manufacturers in Europe: Premier Veterinary Group PLC of the United Kingdom (2015 sales of £2.25 million [US$2.77 million] of which 53% was Buying group), BioPorto A/S of Denmark (20.38 million Danish Kroner [US$3.01 million] ), and Swedencare AB (publ) (26.83 million Swedish Kronor [US$3.04 million] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Enzymatica AB (publ)
  Stock Performance Chart for Enzymatica AB (publ)
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 3.95
(Figures in Swedish Kronor)
1 Week 0.3%   13 Weeks -4.1%  
4 Weeks 63.9%   52 Weeks -12.0%  
Enzymatica AB (publ) Key Data:
  Ticker: ENZY Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 27,912,000
(Year Ending Jan 2016).
Employees: 16
  Currency: Swedish Kronor Market Cap: 289,147,964
  Fiscal Yr Ends: December Shares Outstanding: 73,387,808
  Share Type: Aktie Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.